These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8829015)

  • 1. Cefixime in the treatment of patients with lower respiratory tract infections: results of US clinical trials.
    Quintiliani R
    Clin Ther; 1996; 18(3):373-90; discussion 372. PubMed ID: 8829015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of clarithromycin compared to cefixime as outpatient treatment of lower respiratory tract infections.
    Neu HC; Chick TW
    Chest; 1993 Nov; 104(5):1393-9. PubMed ID: 8222794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefixime. A review of its therapeutic efficacy in lower respiratory tract infections.
    Markham A; Brogden RN
    Drugs; 1995 Jun; 49(6):1007-22. PubMed ID: 7641600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-investigator evaluation of the efficacy and safety of cefprozil, amoxicillin-clavulanate, cefixime and cefaclor in the treatment of acute otitis media.
    Kafetzis DA
    Eur J Clin Microbiol Infect Dis; 1994 Oct; 13(10):857-65. PubMed ID: 7889960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of cefixime versus cefaclor in respiratory tract infections.
    Dorow P
    J Chemother; 1989 Aug; 1(4):257-60. PubMed ID: 2809693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of a new broad-spectrum, beta-lactamase-stable oral cephalosporin, cefixime, in comparison with other drugs, against Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis and Streptococcus pneumoniae.
    Stefani S; Pellegrino MB; D'Amico G; Privitera A; Privitera O; Maccarrone G; Russo G; Nicoletti G
    Chemotherapy; 1992; 38(1):36-45. PubMed ID: 1618002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter surveillance of antimicrobial resistance of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 14 oral antibiotics.
    Hsueh PR; Huang WK; Shyr JM; Lau YJ; Liu YC; Luh KT
    J Formos Med Assoc; 2004 Sep; 103(9):664-70. PubMed ID: 15361938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative, multicenter studies of cefixime and amoxicillin in the treatment of respiratory tract infections.
    Kiani R; Johnson D; Nelson B
    Am J Med; 1988 Sep; 85(3A):6-13. PubMed ID: 3048092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefprozil. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic potential.
    Wiseman LR; Benfield P
    Drugs; 1993 Feb; 45(2):295-317. PubMed ID: 7681376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of respiratory tract pathogens in Finland to cefixime and nine other antimicrobial agents.
    Lehtonen L; Huovinen P
    Scand J Infect Dis; 1993; 25(3):373-8. PubMed ID: 8362234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cefprozil with other antibiotic regimens in the treatment of children with acute otitis media.
    Stutman HR; Arguedas AG
    Clin Infect Dis; 1992 Jun; 14 Suppl 2():S204-8; discussion S209-11. PubMed ID: 1617039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections.
    Perry CM; Scott LJ
    Drugs; 2004; 64(13):1433-64. PubMed ID: 15212560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefixime versus amoxicillin/clavulanic acid in lower respiratory tract infections.
    Beumer HM
    Int J Clin Pharmacol Ther Toxicol; 1989 Jan; 27(1):30-3. PubMed ID: 2663735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of cefixime in pediatric respiratory tract infections].
    Iwai N; Nakamura H; Kasai K; Ozaki T; Matsui Y; Tauchi N; Yamaguchi H; Taneda Y; Maki T
    Jpn J Antibiot; 1991 Jan; 44(1):35-47. PubMed ID: 2041146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of oral cefuroxime axetil and oral amoxycillin/clavulanate in the treatment of community-acquired pneumonia.
    Higuera F; Hidalgo H; Feris J; Giguere G; Collins JJ
    J Antimicrob Chemother; 1996 Mar; 37(3):555-64. PubMed ID: 9182112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Controlled multicentric study comparing cefixime and amoxicillin in the treatment of lower respiratory tract infections in adults].
    Hugues FC; Le Jeunne C
    Presse Med; 1989 Oct; 18(32):1600-4. PubMed ID: 2530542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefixime in the treatment of upper respiratory tract infections and otitis media.
    de Lalla F
    Chemotherapy; 1998 Sep; 44 Suppl 1():19-23. PubMed ID: 9797419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefixime in the treatment of respiratory and urinary tract infections.
    Ludwig E
    Chemotherapy; 1998 Sep; 44 Suppl 1():31-4. PubMed ID: 9797422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of the spectrum and potency of orally administered cephalosporins and amoxicillin/clavulanate.
    Sader HS; Jacobs MR; Fritsche TR
    Diagn Microbiol Infect Dis; 2007 Mar; 57(3 Suppl):5S-12S. PubMed ID: 17292577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.